Viewing Study NCT01300793


Ignite Creation Date: 2025-12-25 @ 1:26 AM
Ignite Modification Date: 2025-12-27 @ 11:56 PM
Study NCT ID: NCT01300793
Status: TERMINATED
Last Update Posted: 2012-09-26
First Post: 2009-09-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Standard-Dose Rituximab, Ifosfamide, Carboplatin and Etoposide
Sponsor: University of California, San Francisco
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module